Elan announced a series of transactions designed to transform the... 
Vortioxetine clinical phase III data show significant improvement in... 
XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen... 
Special Reports
Pharmalot
In what is apparently an unusual move, the US Department of Agriculture earlier this year fined Bristol-Myers Squibb...
After last year marked a notable drop in the value of pharmaceutical thefts, recent data indicates that those Soprano...
1
If there is a take-away message from the $8.5 billion deal in which Actavis is going to buy Warner-Chilcott, it would...
1
Our experts are on hand to offer industry-specific advice.